GE HealthCare Technologies Inc.
For the period ended Dec 31, 2025. Filed Feb 4, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 4, 2026
GEHC$83.65-0.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
| Consolidated Statements of Cash Flows | |||
|---|---|---|---|
| For the years ended December 31 | |||
| (In millions) | 2025 | 2024 | 2023 |
| Net income | $2,154 | $2,050 | $1,614 |
| Less: Income (loss) from discontinued operations, net of taxes | — | — | (4) |
| Net income from continuing operations | 2,154 | 2,050 | 1,618 |
| Adjustments to reconcile Net income to Cash from (used for) operating activities – continuing operations: | |||
| Depreciation of property, plant, and equipment | 287 | 268 | 248 |
| Amortization of intangible assets | 291 | 312 | 362 |
| Gain on remeasurement of Nihon Medi-Physics equity method investment | (97) | — | — |
| Net periodic postretirement benefit plan (income) expense | (267) | (357) | (332) |
| Postretirement plan contributions | (338) | (332) | (357) |
| Share-based compensation | 130 | 125 | 114 |
| Provision for income taxes | 614 | 531 | 743 |
| Cash paid during the year for income taxes | (429) | (491) | (474) |
| Changes in operating assets and liabilities, excluding the effects of acquisitions: | |||
| Receivables | (216) | (157) | (173) |
| Inventories | (142) | (81) | 111 |
| Contract and other deferred assets | (60) | 3 | 10 |
| Accounts payable | 90 | 60 | (100) |
| Contract liabilities | 81 | 68 | 26 |
| Current compensation and benefits | 94 | 39 | 153 |
| All other operating activities – net | (204) | (83) | 151 |
| Cash from (used for) operating activities – continuing operations | 1,987 | 1,955 | 2,101 |
| Cash flows – investing activities | |||
| Additions to property, plant and equipment and internal-use software | (482) | (401) | (387) |
| Dispositions of property, plant, and equipment | — | — | 1 |
| Purchases of businesses, net of cash acquired | (378) | (313) | (147) |
| Purchases of investments | (118) | (40) | (48) |
| All other investing activities – net | (69) | (160) | 23 |
| Cash from (used for) investing activities – continuing operations | (1,047) | (914) | (558) |
| Cash flows – financing activities | |||
| Net increase (decrease) in borrowings (maturities of 90 days or less) | 1 | — | (12) |
| Newly issued debt, net of debt issuance costs (maturities longer than 90 days) | 2,734 | 995 | 2,006 |
| Repayments and other reductions (maturities longer than 90 days) | (1,767) | (1,418) | (855) |
| Dividends paid to stockholders | (64) | (55) | (41) |
| Repurchase of common stock | (200) | — | — |
| Redemption of noncontrolling interests | — | — | (211) |
| Net transfers (to) from GE | — | — | (1,317) |
| Proceeds from stock issued under employee benefit plans | 37 | 33 | 34 |
| Taxes paid related to net share settlement of equity awards | (42) | (93) | (33) |
| All other financing activities – net | (81) | (34) | (49) |
| Cash from (used for) financing activities – continuing operations | 617 | (573) | (478) |
| Cash from (used for) operating activities – discontinued operations | — | (4) | — |
| Effect of foreign currency rate changes on cash, cash equivalents, and restricted cash | 66 | (77) | (10) |
| Increase (decrease) in cash, cash equivalents, and restricted cash | 1,623 | 387 | 1,055 |
| Cash, cash equivalents, and restricted cash at beginning of year | 2,893 | 2,506 | 1,451 |
| Cash, cash equivalents, and restricted cash at end of year | $4,515 | $2,893 | $2,506 |
| Supplemental disclosure of cash flows information | |||
| Cash paid during the year for interest | $(522) | $(550) | $(570) |
| Non-cash investing activities | |||
| Acquired but unpaid property, plant, and equipment | $164 | $143 | $140 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.